Enterovirus (EV) and parechovirus (HPeV) are common viruses in the neonatal period, with similar seasonality and symptomatology. They also are the main causes of aseptic meningitis in newborns and children under 1 year of age. We compared the clinical signs, laboratory data, brain, and neurodevelopmental outcome of 10 infants with HPeV and 8 with EV meningitis. In patients with EV meningitis, serum C-reactive protein (CRP) values were significantly higher than those of patients with HPeV infection. Procalcitonin values were low in both groups. White blood cell (WBC) and lymphocyte values were significantly higher in EV patients. None of the infants had a brain lesion on cerebral ultrasound neither negative neurological outcome. Based solely on symptoms, it is not possible to distinguish HPeV from EV infection. C-reactive protein, WBC, and lymphocyte values might allow the physician to assume EV infection. The gold standard test for diagnosis remains real-time polymerase chain reaction on cerebral spinal fluid.
YunKWChoiEHCheonDSLeeJ, et al. Enteroviral meningitis without pleocytosis in children. Arch Dis Child. 2012;97(10):874-878. doi:10.1136/archdischild-2012-301884.
2.
Outbreaks of aseptic meningitis associated with echoviruses 9 and 30 and preliminary surveillance reports on enterovirus activity—United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52(32):761-764.
SoaresCNCabral-CastroMJPeraltaJMDe FreitasMRGZalisMPuccioni-SohlerM.Review of the etiologies of viral meningitis and encephalitis in a dengue endemic region. J Neurol Sci. 2011;303(1-2):75-79. doi:10.1016/j.jns.2011.01.012.
5.
MeyerHMJohnsonRTCrawfordIPDascombHERogersNG.Central nervous system syndromes of “viral” etiology. Am J Med. 1960;29(2):334-347. doi:10.1016/0002-9343(60)90029-2.
6.
KupilaLVuorinenTVainionpaaRHukkanenVMarttilaRJKotilainenP.Etiology of aseptic meningitis and encephalitis in an adult population. Neurology. 2006;66(1):75-80. doi:10.1212/01.wnl.0000191407.81333.00.
7.
de CromSCvan FurthMAPeetersMFRossenJWObiharaCC.Characteristics of pediatric patients with enterovirus meningitis and no cerebral fluid pleocytosis. Eur J Pediatr. 2012;171(5):795-800. doi:10.1007/s00431-011-1626-z.
8.
RacanielloV.Picornaviridae: the viruses and their replication. In: KnipeDMHowleyPM, eds. Fileds Virology (Vol. 1). Philadelphia, PA: Lippincott William & Wilkins; 2013:453-489.
9.
ZellRDelwartEGorbalenyaAE, et al. ICTV virus taxonomy profile: picornaviridae. J Gen Virol. 2017;98(10):2421-2422. doi:10.1099/jgv.0.000911.
International Committee on Taxonomy of Viruses Executive Committee; GorbalenyaAEKrupovicMMushegianA, et al. The new scope of virus taxonomy: partitioning the virosphere into 15 hierarchical ranks. Nat Microbiol. 2020;5(5):668-674. doi:10.1038/s41564-020-0709-x.
12.
CherryJKrogstadP.Enterovirus, Parechovirus, and Saffold Virus Infections. 8th ed.Philadelphia, PA: Elsevier Health Sciences; 2016.
13.
Enterovirus (nonpoliovirus) (group A and B coxsackieviruses, echoviruses, numbered enteroviruses). In: Committee on Infectious Diseases, American Academy of Pediatrics; KimberlinDWBarnettEDLynfieldRSawyerMH, eds. Red Book: 2021-2024 Report of the Committee on Infectious Diseases. American Academy of Pediatrics; 2021. doi:10.1542/9781610025782-S3_042.
14.
Parechovirus Infections. In: Committee on Infectious Diseases, American Academy of Pediatrics; KimberlinDWBarnettEDLynfieldRSawyerMH, eds. Red Book: 2021-2024 Report of the Committee on Infectious Diseases. American Academy of Pediatrics; 2021. doi:10.1542/9781610025782-S3_095.
15.
TassinMMartinovicJMirandA, et al. A case of congenital echovirus 11 infection acquired early in pregnancy. J Clin Virol. 2014;59(1):71-73. doi:10.1016/j.jcv.2013.11.003.
16.
BendigJWFranklinOMHebdenAK, et al. Coxsackievirus B3 sequences in the blood of a neonate with congenital myocarditis, plus serological evidence of maternal infection. J Med Virol. 2003;70(4):606-609. doi:10.1002/jmv.10437.
17.
KonstantinidouAAnninosHSpanakisN, et al. Transplacental infection of coxsackievirus B3 pathological findings in the fetus. J Med Virol. 2007;79(6):754-757. doi:10.1002/jmv.20887.
18.
ChangMLTsaoKCHuangCCYenMHHuangCGLinTY.Coxsackievirus B3 in human milk. Pediatr Infect Dis J. 2006;25(10):955-957. doi:10.1097/01.inf.0000235686.50060.2b.
19.
BersaniIAuritiCPiersigilliF, et al. Neonatal acute liver failure due to enteroviruses: a 14 years single NICU experience. J Matern Fetal Neonatal Med. 2020;33(15):2576-2580. doi:10.1080/14767058.2018.1555806.
20.
IzumitaRDeuchiKAizawaY, et al. Intrafamilial transmission of parechovirus A and enteroviruses in neonates and young infants. J Pediatric Infect Dis Soc. 2019;8(6):501-506. doi:10.1093/jpids/piy079.
21.
AbzugMJ.Presentation, diagnosis, and management of enterovirus infections in neonates. Paediatr Drugs. 2004;6(1):1-10. doi:10.2165/00148581-200406010-00001.
22.
AbzugMJLevinMJRotbartHA.Profile of enterovirus disease in the first two weeks of life. Pediatr Infect Dis J. 1993;12(10):820-824. doi:10.1097/00006454-199310000-00005.
23.
MorensDM.Enteroviral disease in early infancy. J Pediatr. 1978;92(3):374-377. doi:10.1016/S0022-3476(78)80422-3.
24.
ZhangMWangHTangJ, et al. Clinical characteristics of severe neonatal enterovirus infection: a systematic review. BMC Pediatr. 2021;21(1):127. doi:10.1186/s12887-021-02599-y.
25.
Verboon-MaciolekMAGroenendaalFCowanF, et al. White matter damage in neonatal enterovirus meningoencephalitis. Neurology. 2006;66(8):1267-1269. doi:10.1212/01.wnl.0000208429.69676.23.
26.
LinTYKaoHTHsiehSH, et al. Neonatal enterovirus infections: emphasis on risk factors of severe and fatal infections. Pediatr Infect Dis J. 2003;22(10):889-894. doi:10.1097/01.inf.0000091294.63706.f3.
27.
AbzugMJ.Prognosis for neonates with enterovirus hepatitis and coagulopathy. Pediatr Infect Dis J. 2001;20(8):758-763. doi:10.1097/00006454-200108000-00008.
28.
KadambariSBraccioSRibeiroS, et al. Enterovirus and parechovirus meningitis in infants younger than 90 days old in the UK and Republic of Ireland: a British paediatric surveillance unit study. Arch Dis Child. 2019;104(6):552-557. doi:10.1136/archdischild-2018-315643.
29.
CabrerizoMDíaz-CerioMMuñoz-AlmagroC, et al. Molecular epidemiology of enterovirus and parechovirus infections according to patient age over a 4-year period in Spain. J Med Virol. 2017;89(3):435-442. doi:10.1002/jmv.24658.
30.
BozzolaEBarniSBaroneCPernoCFMaggioniAVillaniA.Human parechovirus meningitis in children: state of the art. Ital J Pediatr. 2023;49(1):144. doi:10.1186/s13052-023-01550-4.
31.
AbzugMJKeyserlingHLLeeMLLevinMJRotbartHA.Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. Clin Infect Dis. 1995;20(5):1201-1206. doi:10.1093/clinids/20.5.1201.
32.
IzumitaRAizawaYSaitohA.A role of intravenous immunoglobulin in human parechovirus type 3 infection in an in vitro model. Open Forum Infect Dis. 2016;3(suppl 1):S1. doi:10.1093/ofid/ofw172.
33.
WildenbeestJGWolthersKCStraverBPajkrtD.Successful IVIG treatment of human parechovirus-associated dilated cardiomyopathy in an infant. Pediatrics. 2013;132(1):e243-e247. doi:10.1542/peds.2012-1136.
34.
AzumaJYamamotoTSakuraiM, et al. Urinary Β2-microglobulin as an early marker of infantile enterovirus and human parechovirus infections. Medicine (Baltimore). 2018;97(43):e12930. doi:10.1097/MD.0000000000012930.
35.
PevearDCTullTMSeipelMEGroarkeJM.Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother. 1999;43(9):2109-2115. doi:10.1128/AAC.43.9.2109.
36.
RotbartHAWebsterAD; for the Pleconaril Treatment Registry Group. Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin Infect Dis. 2001;32(2):228-235. doi:10.1086/318452.
37.
AradottirEAlonsoEMShulmanST.Severe neonatal enteroviral hepatitis treated with pleconaril. Pediatr Infect Dis J. 2001;20(4):457-459. doi:10.1097/00006454-200104000-00022.
38.
AbzugMJMichaelsMGWaldE, et al. A randomized, double-blind, placebo-controlled trial of pleconaril for the treatment of neonates with enterovirus sepsis. J Ped Infect Dis. 2016;5(1):53-62. doi:10.1093/jpids/piv015.
39.
Torres-TorresSMyersALKlatteJM, et al. First use of investigational antiviral drug pocapavir (V-073) for treating neonatal enteroviral sepsis. Pediatr Infect Dis J. 2015;34(1):52-54. doi:10.1097/INF.0000000000000497.
40.
WittekindSGAllenCCJefferiesJL, et al. Neonatal enterovirus myocarditis with severe dystrophic calcification: novel treatment with pocapavir. J Investig Med High Impact Case Rep. 2017;5(3):2324709617729393. doi:10.1177/2324709617729393.
41.
AmdaniSMKimHSOrvedahlAJohnAOSaidASimpsonK.Successful treatment of fulminant neonatal enteroviral myocarditis in monochorionic diamniotic twins with cardiopulmonary support, intravenous immunoglobulin and pocapavir. BMJ Case Rep. 2018;2018:bcr-2017-224133. doi:10.1136/bcr-2017-224133.
